FDA Approves Abilify for Autism-linked Irritability
BusinessWeek
The U.S. Food and Drug Administration has approved top-selling Abilify as a treatment for autism-related irritability in children from the ages of 6 to 17, drug maker Bristol-Myers Squibb Co. said Friday.
Bristol-Myers and Otsuka Pharmaceutical Co., based in Tokyo, are collaborators on the development and distribution of Abilify in the U.S. and Europe.
Abilify is Bristol-Myers’ second-biggest revenue generator, with $2.2 billion in 2008 sales.
The FDA’s latest approval allows the drug to be used to treat symptoms associated with autism such as aggression toward others, deliberate infliction of self-injury, tempter tantrums and moodiness.
The companies said in a statement that it was intended to be used as part of a more comprehensive treatment program that includes educational, psychological and social aspects.
via FDA Approves Abilify for Autism-linked Irritability
Posted on November 23, 2009 | No Comments | Category: Autism, Caregiving | Tags: Autism, Caregiving, Dementia, drug, FDA
Comments
Leave a Reply
